雲能國際(01298.HK)年度收入增加18.7%至3.42億港元
格隆匯3月15日丨雲能國際(01298.HK)公吿,2023年財政年度的收入較2022年財政年度的288.1百萬港元增加53.8百萬港元或18.7%至341.9百萬港元,主要由於分銷業務的收入貢獻較高所致。
2023年財政年度的毛利率為3.0%,而2022年財政年度為4.7%。毛利率減少主要是由於分銷業務於2023年財政年度的毛利率較低,對收入的貢獻增加。
集團於2023年財政年度的虧損較2022年財政年度的8.9百萬港元減少43.8%至5.0百萬港元,主要是由於2023年財政年度錄得金融資產減值虧損撥回淨額。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.